Abstract
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system that
initially is often dominated by relapsing-remitting neurological symptoms. With increasing
disease duration these relapses are more and more superimposed by a progressive disease
process that leads to an irreversible accumulation of motor, sensory and cognitive
deficits. This progressive phase of MS is still only incompletely understood and by
and large refractory to therapy. Here we aim to use recent pathological and pathomechanistic
insights to outline a unifying concept of progressive MS. Based on this view of the
disease we examine current controversies surrounding progressive MS. We discuss whether
neurodegenerative or inflammatory processes drive progression, question whether the
classification of primary and secondary progressive MS is all that useful and deliberate,
which therapeutic strategies are best suited to limit the insidious neurological decline
of progressive MS patients.
Key words
multiple sclerosis - white matter pathology - grey matter pathology - chronic inflammation
- neurodegeneration